Symposium 7: DMT2 with sarcopenia, should we treat them differently?

Authors

  • Cristina De La Mata Private practice, Rosario, Santa Fe, Argentina

DOI:

https://doi.org/10.47196/diab.v56i3Sup.514

Keywords:

diabetes mellitus, sarcopenia

Abstract

In this age that facilitates sedentary lifestyle habits, from primary prevention to the treatment of all clinical forms of diabetes, a lifestyle change that includes physical activity and regular exercise cannot be lacking1.

The background of mitochondrial dysfunction2, especially in the skeletal muscle, and the ability of exercise to reverse it calls for the detection and treatment of Sarcopenia.

Author Biography

Cristina De La Mata, Private practice, Rosario, Santa Fe, Argentina

Endocrinologist

References

I. Haines M, et al. Association between muscle mass and diabetes prevalence independent of body fat distribution in adults under 50 years old. Nutrition and Diabetes 2022;12:29. doi: 10.1038/s41387-022-00204-4.

II. Pinti MV, et al. Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis. Am J Physiol Endocrinol Metab 2019 Feb 1;316(2): E268-E285.doi: 10.1152/ajpendo.00314.2018.

III. Cruz-jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing 2019;48(1):16-31. doi: 10.1093/ageing/afy169.

IV. Ros R, et al. Precision exercise medicine: understanding exercise response variability. Br J Sports Med 2019;53:1141-1153. doi: 10.1136/bjsports-2018-100328.

Published

2022-09-01

How to Cite

De La Mata, C. (2022). Symposium 7: DMT2 with sarcopenia, should we treat them differently?. Journal of the Argentine Society of Diabetes, 56(3Sup), 22–22. https://doi.org/10.47196/diab.v56i3Sup.514

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)